D-Street Buzz: Pharma stocks gain led by Sun Pharma; Titan spikes 4%, RIL most active

The Indian benchmark indices continued to hold steady with the Nifty50 jumping 100 points, trading at 10,879 while the Sensex zoomed 343 points and was trading at 36,148.

Nifty Pharma added over 1.5 percent led by gains from Sun Pharma which spiked close to 4 percent followed by Dr Reddy’s Labs, Piramal Enterprises and Cadila Healthcare.

From the media space, the top gainers were Network 18 which jumped 5 percent followed by Zee Entertainment, Sun TV Network, International EROS and DB Corp.

Midcap stocks were also buzzing led by NBCC, PAGE Industries, Power Finance, REC, Reliance Infra, Reliance Power, Apollo Tyres, Balkrishna Industries, Bharat Forge, Godrej Industries, JSPL, Jubilant Foodworks and Muthoot Finance among others.

The top gainers from NSE include Sun Pharma, Zee Entertainment, IOC, Titan Company and YES Bank while the top losers included Bharti Infratel, Coal India, Asian Paints, Bajaj Auto and Hero Moto.
The most active stocks were Reliance Industries, Titan Company, YES Bank, HDFC Bank and Sun Pharma.

Bata India, Commercial Engineers & Body Builders, Proseed India and SPL Industries have hit new 52-week high on NSE in this afternoon session.43 stocks have hit new 52-week low including names like Adhunik Metaliks, California Software, Mcnally Bharat Engineering, Ortel Communications, Shilpi Cable and Visesh Infotecnics among others.
The breadth of the market favoured the advances with 1151 stocks advancing and 520 declining while 392 remained unchanged. On the BSE, 1551 stocks advanced, 945 declined and 152 remained unchanged.

Disclosure: Reliance Industries Ltd. is the sole beneficiary of Independent Media Trust which controls Network18 Media & Investments Ltd.

  • Related Posts

    • Pharma
    • April 19, 2024
    • 33 views
    US FDA Mandates Label Updates On CAR-T Cancer Therapies

    Washington: The U.S. Food and Drug Administration said on Thursday cancer therapies that use CAR-T technology will require changes to the so-called “boxed warning” to highlight the serious risk of T-cell blood…

    • Pharma
    • April 19, 2024
    • 24 views
    Karnataka Fails To Take Action Against 1,700 Fake Doctors

    Bengaluru: A startling revelation has come to light nearly 17,00 fake doctors have been identified in the AYUSH department in Karnataka. Shockingly, despite these discoveries, no significant action has been taken…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    US FDA Mandates Label Updates On CAR-T Cancer Therapies

    US FDA Mandates Label Updates On CAR-T Cancer Therapies

    Karnataka Fails To Take Action Against 1,700 Fake Doctors

    Karnataka Fails To Take Action Against 1,700 Fake Doctors

    Chhattisgarh Pharmacy Council Issued Certificates For Hundreds Of Fake Pharmacists Without Verification

    Chhattisgarh Pharmacy Council Issued Certificates For Hundreds Of Fake Pharmacists Without Verification

    Gujarat FDCA Approved 133 New Drug Manufacturing Units In FY24

    Gujarat FDCA Approved 133 New Drug Manufacturing Units In FY24

    DCGI Informs SLAs Antibiotic Combo Meropenem 1 Mg & EDTA For Injection Has No Approval

    DCGI Informs SLAs Antibiotic Combo Meropenem 1 Mg & EDTA For Injection Has No Approval

    DCA Raids Two Illegal Pharmacies; Seizes Stocks Of Over 60 Types Of Drugs

    DCA Raids Two Illegal Pharmacies; Seizes Stocks Of Over 60 Types Of Drugs